SCHEMBL30087127

SCHEMBL30087127

CC(C)(C)[Si](C)(C)OCC#Cc1cc(Br)cnc1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27176911 1.00 — —
SCHEMBL27176907 0.83 HPGDS (0.30) —
SCHEMBL30087109 0.83 HPGDS (0.30) —
SCHEMBL1565246 0.82 HTT (0.39) —
SCHEMBL1577309 0.70 AAK1 (0.32) —
SCHEMBL24669715 0.68 — —
SCHEMBL28878932 0.68 AGXT (0.32) —
SCHEMBL29950898 0.68 AGXT (0.32) —
SCHEMBL22866568 0.68 PYCR1 (0.30) —
SCHEMBL31220060 0.67 KDM4E (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4341255-A1 MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS Eli Lilly and Company (US) 2024-03-27 — — EP disclosed
WO-2022246019-A1 MACROCYCLIC GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS ELI LILLY AND COMPANY (US) 2022-11-24 — — WO disclosed
Send feedback